CH. DISCOV. & NON-CLIN DEV OFF · Olema Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$1.33M
Shares
43.7K
Price
$30.4
Executed
Dec 19, 2025
Disclosed
Dec 23, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 19 executedDec 23, 2025 disclosed
OLMA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Myles David C. filed this Form 4 reporting a open-market sale of OLMA on Dec 19, 2025. It became public on Dec 23, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CH. DISCOV. & NON-CLIN DEV OFF
Myles David C.cik:0001831216
Issuer
Olema Pharmaceuticals, Inc.cik:0001750284
Revision history · 0
No field has changed since this record was first ingested.
